2 news items
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
AGIO
14 May 24
of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those regarding the potential benefits of PYRUKYND®
Agios Reports Business Highlights and First Quarter 2024 Financial Results
AGIO
2 May 24
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995
- Prev
- 1
- Next